166 related articles for article (PubMed ID: 37219672)
1. Thymoquinone enhanced the antitumor activity of cisplatin in human bladder cancer 5637 cells in vitro.
Khodadadi F; Khorashadizadeh M; Ghasemi F
Mol Biol Rep; 2023 Jul; 50(7):5767-5775. PubMed ID: 37219672
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of thymoquinone alone or in combination with cisplatin (CDDP) against oral squamous cell carcinoma in vitro.
Alaufi OM; Noorwali A; Zahran F; Al-Abd AM; Al-Attas S
Sci Rep; 2017 Oct; 7(1):13131. PubMed ID: 29030590
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Thymoquinone on Apoptosis of SK-OV-3 Ovarian Cancer Cell by Regulation of Bcl-2 and Bax.
Liu X; Dong J; Cai W; Pan Y; Li R; Li B
Int J Gynecol Cancer; 2017 Oct; 27(8):1596-1601. PubMed ID: 28692636
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
Jafri SH; Glass J; Shi R; Zhang S; Prince M; Kleiner-Hancock H
J Exp Clin Cancer Res; 2010 Jul; 29(1):87. PubMed ID: 20594324
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein.
Ng WK; Yazan LS; Ismail M
Toxicol In Vitro; 2011 Oct; 25(7):1392-8. PubMed ID: 21609759
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone-induced antitumor and apoptosis in human lung adenocarcinoma cells.
Samarghandian S; Azimi-Nezhad M; Farkhondeh T
J Cell Physiol; 2019 Jul; 234(7):10421-10431. PubMed ID: 30387147
[TBL] [Abstract][Full Text] [Related]
7. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
[TBL] [Abstract][Full Text] [Related]
8. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
Ni F; Yan CY; Zhou S; Hui PY; Du YH; Zheng L; Yu J; Hu XJ; Zhang ZG
Cancer Chemother Pharmacol; 2018 Oct; 82(4):593-605. PubMed ID: 30032449
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment.
Ikeguchi M; Nakamura S; Kaibara N
Oncol Rep; 2002; 9(5):1121-6. PubMed ID: 12168083
[TBL] [Abstract][Full Text] [Related]
10. Thymoquinone Augments Methotrexate-Induced Apoptosis on Osteosarcoma Cells.
Sanapour N; Malakoti F; Shanebandi D; Targhazeh N; Yousefi B; Soleimanpour J; Majidinia M
Drug Res (Stuttg); 2022 Apr; 72(4):220-225. PubMed ID: 35385883
[TBL] [Abstract][Full Text] [Related]
11. The Effect of TQ and Cis in OS.
Ahmadzadeh H; Ahmadi M; Golchin A; Malakoti F; Maleki M; Alemi F; Bazavar M; Yousefi B
Drug Res (Stuttg); 2022 Mar; 72(3):171-176. PubMed ID: 35255515
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Proliferation and Induction of Apoptosis by Thymoquinone via Modulation of TGF Family, p53, p21 and Bcl-2α in Leukemic Cells.
Diab-Assaf M; Semaan J; El-Sabban M; Al Jaouni SK; Azar R; Kamal MA; Harakeh S
Anticancer Agents Med Chem; 2018; 18(2):210-215. PubMed ID: 28901264
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone induces apoptosis of human epidermoid carcinoma A431 cells through ROS-mediated suppression of STAT3.
Park JE; Kim DH; Ha E; Choi SM; Choi JS; Chun KS; Joo SH
Chem Biol Interact; 2019 Oct; 312():108799. PubMed ID: 31433961
[TBL] [Abstract][Full Text] [Related]
14. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A
Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells.
Arafa el-SA; Zhu Q; Shah ZI; Wani G; Barakat BM; Racoma I; El-Mahdy MA; Wani AA
Mutat Res; 2011 Jan; 706(1-2):28-35. PubMed ID: 21040738
[TBL] [Abstract][Full Text] [Related]
16. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522.
Mizutani Y; Nakanishi H; Li YN; Sato N; Kawauchi A; Miki T
J Urol; 2004 Oct; 172(4 Pt 1):1474-9. PubMed ID: 15371874
[TBL] [Abstract][Full Text] [Related]
17. Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101).
Mani J; Vallo S; Rakel S; Antonietti P; Gessler F; Blaheta R; Bartsch G; Michaelis M; Cinatl J; Haferkamp A; Kögel D
BMC Cancer; 2015 Apr; 15():224. PubMed ID: 25885284
[TBL] [Abstract][Full Text] [Related]
18. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
[TBL] [Abstract][Full Text] [Related]
19. Thymoquinone attenuates phosphorylation of AKT to inhibit kidney cancer cell proliferation.
Dera A; Rajagopalan P
J Food Biochem; 2019 Apr; 43(4):e12793. PubMed ID: 31353586
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
